Velocity Clinical Research
Private Company
Funding information not available
Overview
Velocity Clinical Research is a pioneering, service-based organization in the digital health sector that operates a large, integrated network of clinical trial sites. Founded in 1986, it has grown to over 70 sites and 200 investigators, having conducted more than 15,000 clinical trials. The company's core value proposition is providing sponsors and CROs with operational efficiency, standardized processes, and advanced patient engagement technologies to accelerate clinical development. It positions itself as a strategic partner for trials ranging from single-site studies to complex, high-volume programs.
Technology Platform
Integrated network of clinical trial sites utilizing unified operational processes and next-generation technologies for patient engagement, recruitment, and data collection to ensure standardized, efficient trial execution.
Opportunities
Risk Factors
Competitive Landscape
Velocity competes with other large site networks (e.g., ICON's Site Alliance, Parexel's network), independent academic research centers, hospital-based sites, and emerging decentralized/virtual trial providers. Its key differentiator is its fully integrated, standardized operational model across a large, owned site network, promising predictability and scale.